Pathology and pathogenesis of bioterrorism-related inhalational anthrax - Wikidata - awgldk - TriplyDB

Pathology and pathogenesis of bioterrorism-related inhalational anthrax

Pathology and pathogenesis of bioterrorism-related inhalational anthrax

http://www.wikidata.org/entity/Q28395786

about

Anthrax lethal toxin downregulates claudin-5 expression in human endothelial tight junctions Does Bacillus anthracis Lethal Toxin Directly Depress Myocardial Function? A Review of Clinical Cases and Preclinical Studies Bacillus anthracis edema factor substrate specificity: evidence for new modes of action Cytoskeleton as an emerging target of anthrax toxins Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility Antimicrobial Treatment for Systemic Anthrax: Analysis of Cases from 1945 to 2014 Identified Through a Systematic Literature Review Histopathology in a murine model of anthrax Bacillus anthracis edema toxin impairs neutrophil actin-based motility Bacillus anthracis' lethal toxin induces broad transcriptional responses in human peripheral monocytes Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax Toxin inhibition of antimicrobial factors induced by Bacillus anthracis peptidoglycan in human blood.Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax Bacillus anthracis-derived edema toxin (ET) counter-regulates movement of neutrophils and macromolecules through the endothelial paracellular pathway.Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculature Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.Bacillus anthracis peptidoglycan stimulates an inflammatory response in monocytes through the p38 mitogen-activated protein kinase pathway.Bacillus anthracis cell wall peptidoglycan but not lethal or edema toxins produces changes consistent with disseminated intravascular coagulation in a rat model.Perturbation of mouse retinal vascular morphogenesis by anthrax lethal toxin.Key tissue targets responsible for anthrax-toxin-induced lethality.Lethality in a murine model of pulmonary anthrax is reduced by combining nuclear transport modifier with antimicrobial therapy.Development of a comprehensive, validated pharmacophore hypothesis for anthrax toxin lethal factor (LF) inhibitors using genetic algorithms, Pareto scoring, and structural biology.Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax Anthrax lethal toxin induces ketotifen-sensitive intradermal vascular leakage in certain inbred mice Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthrax.Molecular determinants for a cardiovascular collapse in anthrax Bacillus anthracis spores stimulate cytokine and chemokine innate immune responses in human alveolar macrophages through multiple mitogen-activated protein kinase pathways Designing inhibitors of anthrax toxin Anthrax lethal toxin induces endothelial barrier dysfunction Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin.Sepsis and pathophysiology of anthrax in a nonhuman primate model Anthrax lethal toxin-mediated disruption of endothelial VE-cadherin is attenuated by inhibition of the Rho-associated kinase pathway Exposing a killer: pathologists angle for anthrax Modeling the host response to inhalation anthrax.Anthrax lethal and edema toxins fail to directly impair human platelet function.Development of an in vitro potency assay for anti-anthrax lethal toxin neutralizing antibodies Highly predictive support vector machine (SVM) models for anthrax toxin lethal factor (LF) inhibitors.Monkeypox transmission and pathogenesis in prairie dogs

P2860

Q24339455-60F5239A-C645-40DD-BCD2-415FBD09B6B3 Q26772000-566F4DAC-F11E-499D-AE29-60D79D678481 Q27000357-82A38E04-0BE3-48D1-A40E-D592D56A1D27 Q27005620-5FF9A87D-1F3D-4269-835E-A849324C59D7 Q27011190-04BEB394-9793-49A5-8AFA-906802BC088C Q28383436-C8E2CD21-8FE6-49F2-BD23-AFF24F983506 Q28383825-BC4FB93E-A660-436E-99EB-006D16426518 Q28385270-DC1E806F-780D-4114-B1B3-F47FCA75EA33 Q28388945-65FACACA-8BE3-4C0F-A9AF-D5F3AEB2C90C Q28389931-D76CD968-EE97-483E-A586-483308EAF79E Q28390214-77771D9E-255D-4E4D-BDCB-A8CC6B3B3897 Q28396018-6DCAF5FD-D834-48C6-80B5-89C0F45A4BA6 Q30414033-E7F0F41E-1B47-42C0-91B3-A312FA58F750 Q30426565-4AB28B55-EE78-47BB-9E54-ACA9DF0ED12E Q30428385-7FA81886-5F8F-4F96-AB08-7435EBF3DA74 Q30481474-BE04B983-B48E-448A-9D7E-8C72F931D551 Q33378594-5BA9727B-E756-40B6-BB2F-2125327E7788 Q33383858-D0203F44-76C4-4D8D-B653-13A98A831D1A Q33408203-67D3AC88-FE93-49DB-9D28-891EF146F5FE Q33502718-8B430C0E-4349-4B6D-BB01-9D268921E191 Q33840430-8A92CB87-CBF3-4CEE-8B0D-7AF947A67DD9 Q34146195-9E49674E-B1D7-4D5F-9F6E-D4E3F2E93C18 Q34304133-419D81E7-1A5B-407E-82FA-961184899FA8 Q34334451-F55D32A0-2400-40C1-9A92-D78262666D29 Q34334465-F7128BC6-BC39-4130-968D-3B407E839B89 Q34483688-BCBA313F-F35D-4526-BFD1-BDBBC4ED7430 Q34960975-1BD0A71D-6914-48E9-BD44-0C3F2ED6093E Q34975815-A9738EAD-A44C-4420-A708-7EBA4D0C74BD Q35018313-296EDA4E-7073-4D80-B730-1B92EEF5C8D0 Q35083943-C59FCB26-BFB1-4055-8DA1-A02207B53258 Q35085358-493495BD-8B62-46A3-B8A0-CE8456EE5B53 Q35155807-4EE5724F-4A59-4577-AF17-2D242CF79BF1 Q35221982-85406298-F453-462E-90DF-751015B6624C Q35534494-636DD4B4-CC68-4FF9-80D1-CF5498B49F20 Q35567843-CFF1A785-347A-4BAE-AC7B-F8F6615F7F4C Q35661015-6EC37914-2F36-4BF4-96A6-7AC45F680D82 Q35669033-2EB1F6B8-D020-4B39-9069-36A5D047C87C Q35749538-662CA430-10F6-4893-8B1D-DB7D19E7B3F6 Q35854901-DBD5C30C-BA25-4448-AD39-B7512F381E86 Q35879326-569E8E41-5C91-465B-9B1E-5286481326FD

P2860

Pathology and pathogenesis of bioterrorism-related inhalational anthrax

http://www.wikidata.org/entity/Q28395786

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Pathology and pathogenesis of bioterrorism-related inhalational anthrax

@ast

Pathology and pathogenesis of bioterrorism-related inhalational anthrax

@en

Pathology and pathogenesis of bioterrorism-related inhalational anthrax

@nl

type

label

Pathology and pathogenesis of bioterrorism-related inhalational anthrax

@ast

Pathology and pathogenesis of bioterrorism-related inhalational anthrax

@en

Pathology and pathogenesis of bioterrorism-related inhalational anthrax

@nl

prefLabel

Pathology and pathogenesis of bioterrorism-related inhalational anthrax

@ast

Pathology and pathogenesis of bioterrorism-related inhalational anthrax

@en

Pathology and pathogenesis of bioterrorism-related inhalational anthrax

@nl

P1433

Q28395786-20D65EB6-C714-45B2-81F3-5B56A92EE145

P1476

Q28395786-2381DA3D-83E8-464A-AFA0-EC00DE2867FC

P2093

Q28395786-08E1A58E-6D51-48D4-9F7E-FBA6F39BC508

Q28395786-9EA99247-8083-41D7-AEFB-E42488BEA0BD

Q28395786-A7209505-F2D1-4AC5-AEC4-9E0BB2B7E068

Q28395786-B660FFF9-EAF9-40FD-97BE-F795F0D7B673

Q28395786-B8E6724B-31A6-4837-BEEE-DC91C0FB6F87

Q28395786-B93D4CE0-D2C9-436F-BD86-C9F7FF4D9CFD

Q28395786-F0A924E3-24D1-47C3-825A-2F2815773497

Q28395786-FA56EF59-340C-4C81-AD49-A4EF04A635E9

Q28395786-FBA6BC51-5530-4135-B29B-BE02A3F9E2C0

P2860

Q28395786-01C3AD47-ACE9-4AEE-BE56-07BEB993566D

Q28395786-1E1B6D61-5E31-4CA0-91E7-5AAE32FB5470

Q28395786-1FCD04B8-2B78-43C2-B636-A60A49F02C64

Q28395786-2549DAF8-EE0C-4B90-AF09-22FE77E34582

Q28395786-2FB2E9C4-C7EF-446B-A786-7D8FD9AF224D

Q28395786-3417DD82-CA07-4C27-9CDF-D9B26AA943E9

Q28395786-3521D9B5-5832-4FAB-9CC9-400F5B6E7441

Q28395786-401E0FA1-049C-497F-AFCB-F1B30D917B56

Q28395786-40BCE6C9-138A-44C7-ACEE-5E9E4817FF8C

Q28395786-41C1B7A5-EB03-4980-A42D-24A0987CF5BB

P304

Q28395786-26EFD152-958D-48E9-A87C-AFF4D3CA73D7

P31

Q28395786-E25B7CB6-CE3E-40FB-BB88-700F8A68CFFD

P3181

Q28395786-0E3BAD39-AD3D-4729-A5F6-CBEAB5E83655

P356

Q28395786-62AE0F99-402E-46D8-83FB-3E0FE6CD8901

P407

Q28395786-685503B7-0472-4B16-A715-F9C942E9E71B

P433

Q28395786-145F6B64-F21B-4C57-985C-ABB3B7015447

P478

Q28395786-600E705A-0EBA-44FF-A36C-BC8993AB01B0

P50

Q28395786-F65D0A0F-9ACE-47C9-AE90-31F830869BBD

P577

Q28395786-A7D5246E-451D-433F-999D-EFDBF78F43A1

P698

Q28395786-57EF274B-9265-484B-9CB4-EF165F80FBEC

P921

Q28395786-66d3cb74-8790-4d7b-b986-1a97435ffc7f

Q28395786-90B7D0AB-762F-4610-9BCC-EEE1CF79CC18

Q28395786-C45127D8-3175-46CB-9484-0531A9868E2C

P932

Q28395786-5F8B39F8-84AB-4EDD-82AE-4EEE9E453471

P3181

P356

S0002-9440(10)63697-8

P1433

The American Journal of Pathology

P1476

Pathology and pathogenesis of bioterrorism-related inhalational anthrax

@en

P2093

Bradley A Perkins

http://www.w3.org/2001/XMLSchema#string

David A Ashford

http://www.w3.org/2001/XMLSchema#string

David S Stephens

http://www.w3.org/2001/XMLSchema#string

Jeannette Guarner

http://www.w3.org/2001/XMLSchema#string

John A Jernigan

http://www.w3.org/2001/XMLSchema#string

Kathleen Tatti

http://www.w3.org/2001/XMLSchema#string

Lisa M Flannagan

http://www.w3.org/2001/XMLSchema#string

Tanja Popovic

http://www.w3.org/2001/XMLSchema#string

Wun-Ju Shieh

http://www.w3.org/2001/XMLSchema#string

P2860

Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States

Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings

Biological and chemical terrorism: strategic plan for preparedness and response - recommendations of the CDC strategic planning workgroup

Quantitative pathology of inhalational anthrax I: quantitative microscopic findings

Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.

Death at Sverdlovsk: what have we learned?

Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.

On the role of macrophages in anthrax

Identification of Bacillus anthracis by using monoclonal antibody to cell wall galactose-N-acetylglucosamine polysaccharide

P304

701-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4515098

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S0002-9440(10)63697-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

163

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12875989

http://www.w3.org/2001/XMLSchema#string

P921

P932

1868222

http://www.w3.org/2001/XMLSchema#string